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Cervical cancer is the fourth most frequent cancer in women with an estimated 570,000 new cases 
globally in 2018. Treatment of advanced cervical cancer is often unsuccessful leading to high 
cancer-related mortality rates, especially in under-resourced countries. Recently, a possible role 
for the cell surface glycoprotein CD24 in host cell specificity of Zika virus was reported. As an 
extension of this work, Zika viruses have been proposed as oncolytic therapy for the 
treatment of neuroblastoma and other CD24 positive tumors. To determine the 
permissiveness of cervical cancer cells to Zika virus infection and its association with CD24, 
we assessed cytopathic effect (CPE) induced by Zika virus in cervical cancer cell lines 
(HeLa, SiHa and CaSki) by light microscopy and by cytotoxicity assay. Cervical cancer cells 
were susceptible to Zika virus-induced apoptosis. Upon infection, the morphology of cervical 
cancer cells changed, exhibiting Zika virus-induced CPE. Cervical cancer cell expression of viral 
non-structural protein 1 (NS1) after infection demonstrated viral protein translation. Quantitative 
plaque assays demonstrated the production of competent virions. Because CD24 expression was 
found to be important for Zika virus infection in neuroblastoma cells, CD24 expression was 
assessed in cervical cancer cells. Cervical cancer cells expressed low but measurable levels 
of CD24 mRNA and protein. siRNA-mediated knockdown of CD24 resulted in reduced 
NS1 expression and reduced levels of virus-induced apoptosis. Taken together our data 
suggest a possible role for CD24 in Zika virus-induced apoptosis in cervical cancer cells. 
Zika virus-induced apoptosis of cultured cervical cancer cells presents the possibility for the use 
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CHAPTER ONE: INTRODUCTION 
Cervical Cancer 
 
The human body is comprised of cells, and when these cells begin to grow out of control, it causes 
cancer. This abnormal cell growth has the potential to invade or spread to other parts of the body. 
Cervical cancer starts in the cervix, specifically in the lining of the cervix. The two parts of cervix 
are namely, endocervix and exocervix (Skinner et al., 2016). These parts are composed of two 
different types of cells – (i) Endocervix is close to the uterus and is covered by glandular cells and, 
(ii) Exocervix is close to the vagina and is lined with squamous epithelial cells. The area where 
endocervix and exocervix meet is called the transformation zone. This is where most cervical 
cancers begin. There are many precancerous developmental stages to cervical cancer (Burd, 2003; 
Williams, Filippova, Soto, & Duerksen-Hughes, 2011).  
 
There are three main types of cervical cancers based on type of cells they are comprised of: - 
1. Squamous cell carcinomas are the most commonly occurring cervical cancer. The features 
of these cancer cells are characterized as squamous cells and this type of cancer develops 
in the exocervix.  
2. Adenocarcinomas develop in the endocervix, from mucus-secreting gland cells. This type 
of cancer is known to be more common from the past few decades.  




Recently, there has been a lot of development in the way cervical cancer is understood especially, 




Human papillomavirus (HPV) infection is one of the most common viral infection occurring in 
sexually active individuals. Most people acquire the infection soon after they become sexually 
active. Infection is not only transmitted by penetrative sex but also transmitted by skin-to-skin 
genital contact (Amador-Molina, Hernández-Valencia, Lamoyi, Contreras-Paredes, & Lizano, 
2013). There are many strains of HPV that can cause infection. HPVs are classified into two types; 
(i) Low-risk HPVs – These can cause warts in genitals, anus, around the mouth or throat. HPV 
types numbered as 6, 11, 43, 54,73, 81 etc; fall under low risk HPVs. Infection caused by low-risk 
HPVs are cleared by the immune system of the body. (ii) High-risk HPV- These HPVs can 
potentially cause cancer if left undetected. HPV 16 and 18 are the two main types of widely studied 
high-risk HPVs (Graham, 2017). 
 
There are many risk factors associated with HPV persistence such as development of cervical 
cancer. Immunocompromised individuals or people with co-infections, such as those living with 
other infections (HIV, HSV, gonorrhea, Chlamydia, etc;) are more susceptible to the progression 
of pre-cancerous infection to cancer (Ghittoni, Accardi, Chiocca, & Tommasino, 2015; Williams 
et al., 2011). Furthermore, age of the mother during first birth, parity and factors like tobacco 
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smoking play a very significant role in the development of cervical cancer from HPV infections 
(Hoffmann, Hirt, Bechtold, Beard, & Raj, 2006).  
 
What are HPVs and how do they cause cancer? HPVs are small icosahedral viruses with a circular 
genome of approximately 8000 bp. The HPV genome can be divided into an early region, encoding 
the early viral proteins E6, E7, E8, E1, E2, E4 and E5, and a late region, encoding L1 and L2 
proteins, which are components of the viral capsid (Graham, 2017). The long control region (LCR) 
is a non-encoding region involved in the control of replication and viral transcription. HPV 
infection is maintained in the basal layer of cervical epithelium as a nuclear episome with little or 
no expression of viral proteins. With keratinocyte differentiation, the HPV genome is expressed 
and replicated (Song, Li, Li, & Dai, 2015). Proteins that are first expressed, regulate viral 
expression of E1 and E2 early viral proteins. Formation of E1 and E2 complexes is required to 
stabilize the binding of E1 helicase to LCR ori site, the first step in vegetative viral genome 
replication. E2 is a transcriptional regulator of early expressed HPV genes; when E2 binds to the 
four E2-binding-domains in the LCR it controls the transcriptional levels of E6 and E7 viral 
oncogenes (Burd, 2003; Ghittoni et al., 2015; Hoffmann et al., 2006). 
 
HPVs infect both skin and mucosal epithelia. Initially, HPVs invade mitotically active basal cells 
of stratified squamous epithelia through micro wounds, using specific cell-surface receptors. In 
basal keratinocytes, viral genomes are produced at 50-100 copies per cell, maintained in episomal 
form and segregated to daughter cells with support from the E1 and E2 early viral proteins 
(Williams et al., 2011). Because there is a minimal expression of viral proteins, HPV infected basal 
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keratinocytes attract little attention from the immune system. As infected keratinocytes 
differentiate and move into the stratum spinosum, there is a massive increase in the expression of 
viral proteins and completion of genome amplification (Song et al., 2015). 
 
Little is known about how innate immune system and HPV interact. Innate and cell mediated 
immunity are downregulated by several specific mechanisms employed by HPV, which facilitate 
immune evasion and persistent viral infection. Oncogenes E2, E6 and E7 interfere with the 
expression of toll-like receptors and IFNs (Tobouti, Bolt, Radhakrishnan, de Sousa, & Hunter, 
2017). Perhaps, as a consequence of their ability to activate the cell cycle and stimulate DNA 
replication, E6 and E7 oncogenes also promote neoplastic transformation of HPV-infected cells. 
E6 and E7 promote proliferation of infected cells, blocking DNA repair and apoptosis, thereby 
leading to genetic mutations and carcinogenesis. Interaction of E6 with critical tumor suppressor 
p53 promotes ubiquitination and subsequent proteosomal degradation. P53 levels rise due to 
cytotoxic stress. E6 also contributes to tumourigenesis by activating telomerase, disrupting 
epithelial-cell adhesion, polarity and differentiation, altering gene transcription and reducing 
immune recognition of infected cells. Deregulation of cell cycle and unchecked proliferation of 
suprabasal cells is caused due to the binding of E7 (Amador-Molina et al., 2013; Castellsagué, 
2008).   
 
Some studies suggest that innate inflammatory pathways that affect HPV replication and viral 
pathogenesis is mediated through NF-ĸB. In canonical pathway of NF-ĸB, the binding of ligands 
such as tumour necrosis factor receptor, a member of the interleukin-1 receptor/toll-like receptor 
 5 
superfamily to the cell membrane allows the recruitment of adaptor proteins such as TNF receptor 
associated proteins (Williams et al., 2011). E2 protein was shown to enhance the activation of NF-
ĸB stimulated by TNF. This was mediated by direct TRAF binding and activation and was 
independent of the NF-ĸB regulator TAX1 binding protein-1 (TAX1BP1). This mechanism might 
be involved in the differentiation of infected keratinocytes, allowing the implementation of the 
productive viral cycle (Tobouti et al., 2017). 
 
In addition to keratinocyte differentiation, there is evidence that suggests innate immune activation 
may be an activator of viral replication. Various cytokines, notably TGF- β, TNF, IL-1 and type 1 
interferon may play roles in stimulating viral replication suggesting that the inhibition of innate 
immune action leads to viral persistence, disease progression and malignant transformation (Burd, 
2003; Skinner et al., 2016). 
Epidemiology Studies of Cervical Cancer and HPV Vaccination 
 
Globally, cervical cancer is the fourth most frequent cancer in women with approximately 570,000 
new cases in 2018 alone, representing 7.5% of all female cancer-associated deaths. 311 000 deaths 
out of 570,000 every year, i.e. over 85% of these occur in under-resourced countries (Castellsagué, 
2008). 
 
There are several programs available in developed countries which enable HPV vaccination of 
girls and screening of women regularly. Pre-cancerous lesions can be identified during the 
screening process at the early stages, and this allows the patients to undergo necessary treatment. 
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Early identification and treatment help in the prevention of 80% cervical cancers in developed 
countries (Hagemann et al., 2007; Sagae et al., 2016). However, in developing countries, cervical 
cancer is often not identified until certain symptoms develop or it has advanced due to lack of 
preventive measures. Furthermore, treatment options for such late-stage cervical cancer may also 
be limited, resulting in a higher cervical cancer-associated mortality rate. Treatment options for 
cervical cancer are based on the stage and type of cancer identified. Most treatment options for 
cervical cancers include surgeries; there are also many new techniques that are being developed, 
such as immunotherapy, targeted therapies, etc (Ghittoni et al., 2015; Unno et al., 2005). 
CD24 
 
CD24 is a cell surface glycoprotein that encodes a sialoglycoprotein expressed on mature 
granulocytes and B cells. CD24 is known to modulate growth and differentiation in B cells and 
granulocytes (Elghetany MT, 2002; Hough MR, 1994).  CD24 expression is associated with 
diverse functions like adaptive immune response, inflammation and as markers on the cancer cells 
(Lee, Smeriglio, Dragoo, Maloney, & Bhutani, 2016). 
 
CD24 is considered a crucial marker in cancer diagnosis and prognosis. Silencing CD24 mRNA 
and antibody blocking in tumor cells suggest an instrumental role for CD24 in tumor cell 
proliferation and survival (Hough MR, 1994; MLA Pei, 2016; Parlato M, 2014). In breast cancer 
and esophageal carcinoma, cell surface and cytoplasmic expression of CD24 correlates to tumor 
metastasis in lymph nodes. Also, CD24 expression is considerably high in invasive carcinomas 
(Kristiansen et al., 2003; W. Li et al., 2017; Sano, 2009).  
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CD24 plays a vital role in cancer pathogenesis of various human malignancies. However, the 
correlation of CD24 expression with uterine cervical cancer, the underlying mechanisms and its 
prognostic significance still remain unknown. Some studies show an association of CD24 with 
tumor progression and prognosis of cervical cancer, indicating that it could serve as a potential 
prognostic marker. In other cases, it has been shown that CD24 influences apoptosis of cervical 
cancer cells (Fang, Zheng, Tang, & Liu, 2010; Hough MR, 1994; MLA Pei, 2016). 
Zika virus 
 
Zika virus was first isolated in a rhesus monkey by yellow fever sponsored research program. Zika 
virus belongs to the family Flaviviridae and is single-stranded, linear, positive-sense RNA virus 
whose genome is 10,794 kb (Musso & Gubler, 2016). The open reading frame (ORF) of Zika virus 
encodes for a polyprotein with three structural proteins, capsid, premembrane, and envelope 
proteins, and seven nonstructural proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 (Shao 
et al., 2017). 
 
Zika virus is transmitted by the vectors Aedes aegypti and Aedes albopistus, these species of 
mosquitoes are also known to transmit dengue and chikungunya viruses. Non-vector borne 
transmission of Zika virus includes laboratory contamination, sexual transmission, maternofetal 
transmission, and transfusion-transmitted infections (Lazear & Diamond, 2016; H. Li et al., 2016). 
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Zika virus commonly causes asymptomatic infections. The incubation period for Zika is estimated 
to be 3 – 14 days.  The asymptomatic nature of Zika virus infection may lead to patients not seeking 
medical care. Also, this disease mostly occurs in countries that lack standardized medical facilities. 
However, in the case of maternofetal transmission, pregnant mothers gave birth to newborns who 
exhibited severe malformations with some newborns being microcephalic (Lovagnini Frutos et al., 
2018; Rasmussen, Jamieson, Honein, & Petersen, 2016; Shao et al., 2017).  
In 2015, based on the numerous cases reported in Brazil, Zika virus infection was associated with 
Guillain-Barre syndrome. In 2017, nearly 120 million people were affected by Zika virus infection 
in Brazil, 32 million cases in Mexico and 29.5 cases in Columbia. Brazil was affected the most by 
this epidemic. In the United States, a total number of 72 cases have been reported, and 148 cases 
have been reported from US territories according to most recent reports. (Sager, 2018). 
The Life-Cycle of Zika Virus 
The genome of Zika virus lacks a poly-a tail that codes for the structural proteins (Capsid, 
envelope, and premembrane proteins) in the N-terminal and non-structural proteins responsible for 
RNA replication and evasion of the host anti-viral response (NS1-NS5A) (Musso & Gubler, 2016). 
Zika virus RNA translation is initiated in the cytoplasm soon after the virion is released into the 
host cell. The signal present on the N-terminal of the polyprotein aids in achieving ER-localization. 
The signal stimulates the rapid association of ribosomes to translate the viral RNA with the ER 
membranes. This results in co-translational insertion of the growing polyprotein into the ER, 
leading to a complex distribution of the individual protein domains: PrM, E, NS1 and some 
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extended stretches of NS2A, NS4A and NS4B are located intraluminally, while C, NS3, and NS5 
are facing the cytoplasmic side of the ER, with several transmembrane sequences present in NS2A, 
NS2B and NS4B traversing the ER membrane bilayer (Lovagnini Frutos et al., 2018; Musso & 
Gubler, 2016; Sager, 2018).  
 
The polyprotein is processed into individual peptides by virally-encoded protease complex NS2B-
NS3 that cleaves bonds exposed on the cytoplasmic side of the ER, as well as cellular proteases 
including signal peptidase that cleave bonds located in the lumen of the ER. The Golgi-resident 
protease furin performs the final cleavage of the glycoprotein prM to generate its mature form M, 
required for virion infectivity (H. Li et al., 2016). The non-structural proteins form replication 
complexes on modified ER membranes and first transcribe genomic positive-sense RNA into a 
minus strand RNA that serves as a template for producing multiple copies of progeny positive-
sense RNAs. The newly-synthesized positive-sense RNAs can be either recruited for further 
rounds of translation or incorporated into virions, which also initiate their assembly on ER 
membranes. Virions that are assembled, travel to secretory pathways which undergo maturation 
until their final release into extracellular space (Calvet, Santos, & Sequeira, 2016; Lazear & 









Oncolytic viruses are viruses that can selectively replicate in a tumor without causing any damage 
to healthy tissue. The oncolytic ability of a virus depends on the host-virus interaction specificity, 
virus biology, evolution and potential pathogenesis to the host. There are two categories of 
oncolytic viruses: (i) viruses that are innately capable of replicating inside of tumor cells, 
preferentially. This category includes Newcastle disease virus and few other pox viruses; and (ii) 
viruses that are genetically manipulated to be able to cause damage to the tumor, such as poliovirus, 
herpes simplex virus, etc (Chiocca & Rabkin, 2014; Sokolowski, Rizos, & Diefenbach, 2015; 
Zamarin & Palese, 2012). 
 
Oncolytic viruses have several beneficial features which make them feasible for oncolytic therapy: 
(i) likelihood of developing resistance to oncolytic viruses are low as they target multiple 
oncogenic pathways; (ii) they are selective to the tumor and not pathogenic to healthy tissue; (iii) 
since some of the oncolytic viruses are considered non-pathogenic, they can be administered 
intravenously, which is simpler than targeted intratumoral administration. The effectiveness of the 
viral therapy will depend on the tumor cell phenotype, specificity, permissiveness, non-
pathogenicity and thus not trigger any anti-viral immune pathways in the host (Chiocca & Rabkin, 
2014; Sokolowski et al., 2015). 
 
Previously, the oncolytic potential of Zika virus has been assessed in neuroblastomas and 
glioblastomas (Mazar et al., 2018; Zhu et al., 2017). Unlike many lethal cancers, glioblastomas 
rarely metastasize out of the central nervous system (CNS), and the recurrence rate is high in most 
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of the patients (Chen et al., 2018; Wallner, Galicich, Krol, Arbit, & Malkin, 1989; Zhu et al., 2017). 
Zika virus infects the developing CNS, with neural stem and progenitor cells prominently affected. 
Neural precursors infected by Zika virus undergo differentiation, loss of proliferation, and cell 
death. As mentioned before, the effects of Zika virus in adults are generally less severe, with rare 
cases of meningoencephalitis, suggesting that ZIKV infection has fewer deleterious effects in the 
adult brain (Lovagnini Frutos et al., 2018; Parra et al., 2016). Based on the observations made on 
the oncolytic potential of Zika virus and given the benign course of Zika virus infection in non-







CHAPTER TWO: MATERIALS AND METHODS 
Cell lines, Viruses and Culture Conditions. 
 
Cell lines HeLa, SiHa, CaSki, and IMR-32 were purchased from ATCC. HeLa and SiHa cells were 
cultured in Advanced MEM + GlutaMAXTM (Gibco Life Sciences), CaSki cells were cultured in 
RPMI – 1640 + GlutaMAXTM, IMR-32 cells were cultured in MEM Alpha + GlutaMAXTM. All 
media were supplemented with 10% FBS. Cells were maintained and incubated in 37O C and 5% 
CO2. Zika virus strain used in all experiments is MR766, isolated from a rhesus monkey from 
Uganda. The viral stock was kindly provided by Dr. Griffith Parks’ lab (University of Central 
Florida). 
Cell Line Infection and Death Assay 
 
2 x 104 cells were seeded in a 96-well tissue culture treated plate (n=6) and the cells were allowed 
to attach overnight. Next day the cells were infected with Zika virus strain MR766 of MOI-1 and 
-10 along with CellToxTM Green Dye as per the instructions in CellToxTM Green Cytotoxicity 
Assay (Promega #G8741) protocol. The control cells were treated with conditioned media. Cells 
were maintained and incubated in 37O C and 5% CO2. Samples were read for five days at 24-hour 
interval, starting immediately after the infection (0, 24, 48, 72 and 96 hours). All the samples were 
read using a SpectraMax M5 (Molecular Devices Corp.) system at an excitation wavelength of 
490 nm using SoftMax Pro (version 6.2.1) software. 
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Images by Light Microscopy 
 
1 x 105 cells were seeded in a 6-well tissue culture treated plate (n=3) and the cells were allowed 
to attach overnight. Following day, the cells were infected with Zika virus strain MR766 of MOI-
1 and control cells were treated with conditioned media. 16-18 hours after infection the old media 
was replaced with fresh media after cells were gently washed with PBS. Cells were maintained 
and incubated in 37O C and 5% CO2. The cells were imaged using EVOSTM M5000 imaging 
system (ThermoFisher Scientific #AMF5000) for four days or till all the infected cells were dead.  
Reverse Transcription and Real-Time PCR 
 
Total RNA from 106 cells was isolated using TRI Reagent (Zymo Research #R2050-1-200) and 
Quick RNA Miniprep kit (Zymo Research #R1055). RNA concentrations were determined using 
UV spectrophotometry. cDNA was synthesized using the High Capacity cDNA Reverse 
Transcription Kit (Applied BiosystemsTM #4368813). Synthesized cDNA was used to perform 
Real-Time PCR using SsoFast™ EvaGreen® Supermix (Bio-Rad #1725200) in CFX384 TouchTM 
Real-Time PCR Detection System (BioRad #1855484). Primers for both CD24 and GAPDH were 
obtained from Integrated DNA Technologies (IDTS). PrimerQuest was used to generate the gene-
specific primer sequences. CD24 forward primer 5’ – TCAAGTAACTCCTCCCAGAGTA – 3’, 
CD24 reverse primer 5’ – AGAGAGTGAGACCACGAAGA - 3’ and GAPDH forward primer 5’ 
– ACATCGCTCAGACACCATG – 3’, GAPDH reverse primer 5’ – 
TGTAGTTGAGGTCAATGAAGGG -  3’.  GAPDH was used to normalize copy number values 
to determine relative copy numbers across all cell lines.  
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Western Blot Analysis of CD24 
 
Total protein was extracted from 106 cells and denatured by boiling with 2X Laemmli sample 
buffer (Bio-Rad #1610737) at 950 C. Extracted protein was subjected to SDS-PAGE for separation. 
After separation, the protein was transferred onto a 0.2 um nitrocellulose membrane (BioRad, Cat# 
1620112). The membrane was blocked with 5% non-fat dry milk and probed with anti-CD24 
antibody (ThermoFisher, Monoclonal SN3, # MA5-11828) at 1/200 and anti-GAPDH antibody 
(Santa Cruz #FL-335) at 1/2000. After probing with the mentioned primary antibodies, the 
membrane was probed with HRP conjugated secondary antibodies (Invitrogen, Goat anti-Mouse 
#62–6520) and visualized with SuperSignal™ West Pico PLUS Chemiluminescent Substrate 
(ThermoFisher Scientific #34580).  
Western Blot Analysis of Non-Structural Protein 1 
 
3 x 105 cells were seeded in a 6-well tissue culture treated plate and the cells were allowed to attach 
overnight. Following day, the cells were infected with Zika virus strain MR766 with MOI of 1 and 
control cells were treated with conditioned media. 16-18 hours after infection the old media was 
replaced with fresh media after cells were gently washed with PBS. Cells were maintained and 
incubated in 37O C and 5% CO2. Cells were collected at 48-hour and 72-hour time points after 
infection. Protein was extracted from these cells and denatured by boiling with 2X Laemmli 
sample buffer (Bio-Rad #1610737) at 950 C. Extracted protein was subjected to SDS-PAGE for 
separation. After separation, the protein was transferred onto a 0.2 um nitrocellulose membrane 
(BioRad, Cat# 1620112). The membrane was blocked with 5% non-fat dry milk and probed with 
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Anti-Zika Virus NS1 antibody (Abcam #ab218546) at 1/1000, anti-Zika virus Envelope antibody 
(Env) (GeneTex # GTX133314) at 1/1000, and anti-GAPDH antibody (Santa Cruz #FL-335) at 
1/2000. After probing with the mentioned primary antibodies, the membrane was probed with HRP 
conjugated secondary antibodies (Invitrogen, Goat anti-Mouse #62–6520, Goat anti-Rb #65–
6120) and visualized with SuperSignal™ West Pico PLUS Chemiluminescent Substrate 
(ThermoFisher Scientific #34580).  
Transient Transfection and Non-structural protein 1 expression analysis 
 
3 x105 cells were seeded in a 6-well tissue culture treated dish and the cells were allowed to attach 
overnight. The next day, the cells were transfected with 15 pmole of CD24 Silencer Select Pre-
designed siRNA (# 4392420, ID: s2616) or Silencer Select Negative Control siRNA #1 (# 
4390843) using Lipofectamine RNAiMax transfection reagent (ThermoFisher Scientific # 
13778150). 4-6 hours after transfection the media was replaced. Cells were maintained and 
incubated in 37O C and 5% CO2. 48-72 hours after transfection, the cells were collected for total 
RNA isolation and Real-Time PCR was performed with the synthesized cDNA to confirm the 
knockdown efficiency of CD24. GAPDH was used to normalize copy number values.  
 
3.5 x 105 transfected cells were seeded in a 6-well tissue culture treated dish and the cells were 
allowed to attach overnight. The cells were infected with Zika virus strain MR766 with MOI of 1 
and control cells were treated with conditioned media. Cells were maintained and incubated in 37O 
C and 5% CO2. Cells were collected at 48- and 72-hours post infection for NS1 western blot 
analysis.  
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Caspase 3/7 Assay 
 
2 x 104 cells were seeded in a 96-well tissue culture treated plate in 12 wells and the cells were 
allowed to attach overnight. Next day the cells were infected with Zika virus strain MR766 with 
an MOI of 1 and medium for corresponding cell line was used to subtract the background 
luminescence. Cells were maintained and incubated in 37O C and 5% CO2. All cells and media 
were treated with Caspase-Glo® 3/7 reagent 48 hours after infection. The luminescence was read 
at excitation wavelength 490nm. All the samples were read using SpectraMax M5 (Molecular 
Devices Corp.) system at an excitation wavelength of 490 nm using SoftMax Pro (version 6.2.1) 
software. Similarly, the transfected cells, SiHa, and CaSki (Control/mock, siRNA negative control, 
siRNA CD24 knockdown cells) were tested for Zika virus induced apoptosis.  
Plaque Assay 
 
3 x 105 cells were seeded in a 6-well tissue culture treated dish and the cells were allowed to attach 
overnight. Each cell line was seeded in triplicates. Following day, the cells were infected with Zika 
virus strain MR766 with MOI of 1 and control cells were treated with conditioned media. 16-18 
hours after infection the old media was replaced with fresh media after cells were gently washed 
with PBS. Cells were maintained and incubated in 37O C and 5% CO2. 90ul of media was sampled 





Plaque assay was performed by Dr. Griffith Parks’ lab (University of Central Florida). Previously 
collected virus samples were diluted using DMEM (containing 10% BSA). For 24hr & 96hr flash 
frozen samples were serially diluted to 102 - 104 and 48hr & 72hr samples were serially diluted to 
103 - 105 dilutions. Vero cells were used as indicator cells. Vero cells were seeded in monolayer 
and was ensured that Vero cells were at 90-95% confluency. 500ul of the virus previously collected 
was added to wells and incubated at 37 ºC, gently rocking every 15 mins. For Agarose Overlay, 
1:1 mixture of warmed (at 56 ºC) 2x DMEM (containing 4% FBS) and 1.2% Agarose was used. 
The media/virus was discarded and cells were washed with PBS. 2mL of agarose mix was added 
to each well and allowed to solidify with the lid open for 7mins. The plates were incubated at 37 
ºC for 6 days in an upright position. Following which the plates were incubated in 2mL of 3.7% 
formaldehyde in 1x PBS for 3 hours. After 3 hours, the formaldehyde was removed and 2mL of 
crystal violet (1% crystal violet in 20% ethanol) solution was pipetted into the wells gently. Plates 
were covered with aluminum foil and incubated at room temperature for 30 mins. Crystal violet 
solution was removed and the plates were gently washed with water and inverted to dry. Once the 
plates were dry, the plaques were counted. 
Figures and Statistics 
 
Averages and standard deviations were generated using Microsoft Excel®. To generate P values, 
two-tail and students t-test methods were used, and P-values are statistically significant for p<0.05. 




CHAPTER THREE: RESULTS 
Cervical Cancer Cells are Permissive to Zika virus Infection 
 
To determine if cervical cancer cells are susceptible to Zika virus infection, three cervical cancer 
cell lines- HeLa, SiHa and CaSki were used. A neuroblastoma cell line, IMR-32 was used as a 
positive control as its permissiveness to Zika virus infection has previously been established 
(Mazar et al., 2018). All the four cell lines were infected with two different MOIs, MOI-1 and 
MOI-10 to gauge the susceptibility to Zika virus infection and hence permissiveness (Fig. 1). 
MR766 strain Zika virus was used for the infections performed. Uninfected controls were treated 
with conditioned media. Fluorescence of samples was measured to obtain the death rate of cells 
every day for four days, starting from the time of infection (day 0). In SiHa and CaSki cells, the 
samples infected with both MOIs exhibited a higher death rate right from day 1 (24 hours dpi) 
compared to that of uninfected samples, whereas in HeLa cells death rate remained the same for 
both infected and uninfected samples initially (Fig 1B – 1D). IMR-32 exhibited a higher death rate 
in uninfected samples (both MOIs) owing to the high baseline apoptosis rate of the cell line while 
the infected samples showed lower death rate till day 2 (48 hours dpi) (Fig 1A).  By day 3, 90-
100% of infected HeLa and CaSki cells were dead while only about 40% of infected IMR-32 and 
SiHa cells were dead. Surprisingly, the death rates were considerably higher in cells infected with 





Figure 1: Kinetics of Zika virus-induced cell death in cervical cancer cells 
IMR-32, HeLa, SiHa and CaSki (A-D, respectively) cell lines were treated with Zika virus of MOIs 
1 and 10. Along with two infected conditions, uninfected controls were used to measure baseline 
apoptosis in each cell line. The graphs show cytotoxicity measured across corresponding time 
points starting from day 0, for every 24 hours until day 4 for IMR-32 and SiHa and until day 3 for 
HeLa and CaSki. CellToxTM Green Cytotoxicity Assay was used to measure the cytotoxicity. The 
results were normalized using uninfected samples treated only with CellToxTM reagent. The graphs 








Non-structural protein 1 is a glycosylated viral protein. NS1 is associated with lipids and plays a 
role in the formation of homodimers inside the cells and is necessary for infection and viral 
replication of Zika virus. Non-glycosylated envelope proteins of Zika virus are responsible for the 
entry of the virus into the host cell via endocytosis. To confirm viral replication after infection in 
cervical cancer cells, we measured expression levels of NS1 and envelope proteins. All the three 
cell lines were infected with Zika virus of MOI-1 and the controls with PBS, IMR-32 cells were 
used as a positive control. At 48 and 72 hours after infection, cells were collected for protein 
isolation. Protein lysates from 48- and 72-hour time points were used, along with uninfected 
controls to run a western blot (Fig 2A). Expression of GAPDH was used as the loading control. 
The results from western blot revealed that all the cervical cancer cell lines expressed NS1and 
envelope proteins at both the time points, with significantly higher expression at the 72-hour time 
point.  
 
Apoptosis is a critical component of cell growth and development. Apoptosis aids the organism in 
ridding of DNA-damaged cells and minimizes threats by destroying virus-infected cells. Apoptotic 
cells exhibit an array of morphological and biochemical changes. Caspases belong to a family of 
cysteine-aspartic acid proteases that cause these morphological and biochemical changes. 
Caspases cleave cellular proteins and play various roles in the initiation and execution of apoptosis. 
Hypothesizing that virus-induced death is caused by apoptosis, we performed a caspase 3/7 assay 
to determine the mechanism of virus-induced cell death in cervical cancer cell lines. Hela, Siha 
and CaSki cells along with IMR-32 cells were infected with MOI-1 of Zika virus. Samples treated 












Figure 2: Zika virus infected cervical cancer cells express the viral NS1 protein and cellular 
caspases. 
A. Western blot analysis of cervical cancer cells following Zika virus infection. Hela, SiHa and 
CaSki cells were infected with MOI-1 of Zika virus. Cells from 48 and 72- hour time points were 
harvested for NS1 and envelope protein analysis. IMR-32 was used as positive control and 
GAPDH as the loading control. B. Caspase 3/7 assay was performed 48 hours following infection 
using IMR-32, HeLa, SiHa and CaSki to measure Zika virus infection associated apoptosis. 
Uninfected cells were used to detect baseline apoptosis in cells. C. Bright field microscopy images 
of HeLa, SiHa and CaSki were taken 72 hours after infection to show cytopathic effect experienced 
by the cells. The graphs represent the means of the luminescence readings obtained after 
subtracting the background measured from medium only (n=3). The error bars represent the 
standard deviation of the means. P-values were calculated using student's T-test, and values are 
significant for p<0.05. 
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48 hours’ post-infection the samples were treated with Caspase-Glo® 3/7 reagent and incubated at 
room temperature for an hour before the luminescence readings were obtained. Untreated media 
was used to get the background luminescence. Apoptosis was significantly higher in IMR-32 and 
CaSki cells treated with the virus compared to the uninfected controls. In contrast to the high level 
of apoptosis seen in IMR-32 and CaSki cells, the difference in apoptosis between infected and 
uninfected HeLa and SiHa cells was considerably lower. 
 
To quantify the production of infectious virions in cells after infection, quantitative plaque assays 
were performed. For the quantitative plaque assays, cervical cancer cells were first treated with 
Zika virus of MOI-1 for 16-18 hours after which the media was replaced. Following the 
replacement of the media, fresh media from the infected cells was sampled at the indicated time 
points (Fig 3.). Viral titers at corresponding time points were measured by counting the plaques. 
As 90-100% of HeLa and CaSki cells undergo lysis by the 72-hour after infection, media was 
sampled until day 3. In contrast, media from IMR-32 and SiHa cells could be harvested until day 
5 post-infection. As shown in the figure (Fig 3.), the viral titers increase during the earlier time 
points in all cell lines and gradually decrease as host cells undergo virus-induced lysis. This 









Figure 3: Cervical cancer cells support productive Zika virus infection 
Viral titers in IMR-32, HeLa, SiHa, and CaSki cells are obtained from plaque assay. Cells were 
infected with MOI of 1 for 16-18 hours following which the media was replaced. The supernatant 
was sampled for every 24 hours starting from day 1 (24 hours dpi). The number of infectious virus 
units was determined by plaque assay, and the graph was plotted on a log scale. Each point on the 
graph indicates the mean of the number of plaques obtained at the corresponding time point (n=3). 








Cervical cancer cells express cell surface glycoprotein CD24 
 
CD24 is a heavily glycosylated cell surface protein. CD24 is associated with invasion and 
metastasis in most cancers. However, in cervical cancer the function of CD24 is unclear. Recently, 
a possible role of CD24 was explored in neuroblastoma cell lines for Zika virus infection 
associated host cell specificity (Mazar et al., 2018). 
 
Real-time PCR and Western blot techniques were employed to measure CD24 expression. IMR-
32 cells were used as positive control. Cervical cancer cells were collected for RNA and protein 
isolation. Samples from RNA isolation was used to synthesize cDNA and perform real-time PCR. 
The results from real-time PCR revealed that the expression of CD24 mRNA was slightly higher 
in CaSki cells compared to HeLa and SiHa cells (Fig 4A.). IMR-32 cells expressed high CD24 
mRNA levels when compared to cervical cancer cells. Western blot analysis of the whole cell 
lysates through SDS-PAGE confirmed the results of real-time PCR, wherein we observed that 
CD24 protein expression was substantially higher in IMR-32 cells compared to cervical cancer 




Figure 4: Cervical cancer cells express low levels of CD24 mRNA and protein 
A. The real-time PCR analysis of IMR-32, HeLa, SiHa, and CaSki. Real-time PCR analysis was 
performed using the RNA collected from each cell line. The RNA concentration was standardized. 
GAPDH was used as the housekeeping gene to obtain the relative CD24 mRNA expression. Error 
bars represent standard error of the means (n=3). mRNA expression is showed in terms of fold 
change over GAPDH and then normalized to IMR-32 CD24 mRNA expression. B. Western blot 
analysis of CD24 expression. Whole cell lysates were used to run the western blot. GAPDH was 

















Correlation between CD24 expression and permissiveness to Zika virus infection 
 
To demonstrate the correlation between CD24 expression and Zika virus infection, CD24 protein 
expression was reduced using siRNA transfection. SiHa and CaSki cells were transfected with 
either anti-CD24 or negative control siRNAs. Four hours following transfection the media was 
replaced to remove transfection complexes. Subsequently, 48 hours after transfection, the 
transfected cells were harvested along with untransfected controls for Zika virus infection and for 
real-time PCR to test the knockdown efficiency. Real-time PCR showed siRNA-induced-
knockdown efficiency in CD24 mRNA expression in both SiHa and CaSki cells to be 80-90%. 
 
Transfected cells and untransfected control cells were infected with Zika virus. Bright field 
microscopy images of all infected cells were obtained at the indicated time points (Fig 5E. and 
5F). Untransfected (CD24 expressing) cells died quickly, and the cells floated to the surface of the 
media. Transfected cells remained relatively adherent and exhibited normal morphology.  
 
Western blot analysis of protein isolates of transfected cells harvested after the infection showed 
a definite reduction in NS1 production in CaSki cells (while expression of envelope protein was 
not affected). Infection of SiHa cells led to little if any change in NS1 expression. GAPDH was 
used as the loading control.  
 
A caspase 3/7 assay was performed on transfected samples to measure the apoptosis levels after 
siRNA-mediated CD24-knockdown and Zika virus infection (Fig 5C). Zika virus infection of 
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CD24-knockdown CaSki cells exhibited decreased rates of apoptosis compared to Zika virus 
infected control (untransfected and siRNA negative control) cells. Thus, in CaSki cells silencing 
of CD24 in some way confers protection against Zika virus-induced apoptosis. 
 
In contrast to CaSki cells in which CD24 silencing had an anti-apoptotic effect, CD24 silencing in 



















Figure 5: siRNA-mediated silencing of CD24 expression leads to decreased Zika virus-
induced apoptosis and NS1 expression in cervical cancer cells 
A. & B. CD24 Knockdown efficiency in SiHa and CaSki cells was tested through real-time PCR. 
Real-time PCR was performed using the RNA collected from each cell line (Transfected and 
untransfected). The RNA concentration was standardized. GAPDH was used as the housekeeping 
gene to obtain the relative CD24 mRNA expression. Error bars represent standard error of the 
means (n=3). mRNA expression is showed in terms of fold change over GAPDH and then 
normalized to untransfected cells’ CD24 mRNA expression. C. Caspase 3/7 assay was performed 
48 hours following infection (MOI-1) in all the indicated cells to measure Zika virus infection-
associated apoptosis. Uninfected mock cells were used to detect baseline apoptosis in cells. The 
graphs represent the means of the luminescence readings obtained after subtracting the background 
obtained from medium only (n=3). The error bars represent the standard deviation. P-values were 
calculated using the student's T-test. D. For western blot analysis, transfected and untransfected 
cells were infected with an MOI of 1 of Zika virus and cells from 48-hour time point were 
harvested for NS1 and envelope protein analysis. GAPDH was used as the loading control. E & 
F. Bright field images of Zika virus infected SiHa (F) and CaSki (E) cells were taken after 
siRNA-mediated knockdown of CD24 in SiHa and CaSki cells along with corresponding siRNA 
negative control cells and mock/untransfected cells, every 24 hours for 4 days.
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CHAPTER FOUR: CONCLUSIONS 
HPV infections underlie more than 99% of cervical cancers; 70% of cervical cancers are caused 
by HPV types 16 and 18. HPV infection is common, and in most cases, resolves spontaneously 
(Castellsagué, 2008). However, infections caused by high-risk HPVs are not cleared as frequently 
and become persistent. These persistent infections caused by high-risk HPV strains have the 
potential to cause cervical cancers ultimately (Burd, 2003). 
 
HPV infections can be prevented by HPV vaccines. Although, HPV infection has no cure 
currently, abnormal cell growths and warts caused by HPV can be excised; premalignant cells are 
removed before progression to cancer (Amador-Molina et al., 2013; Ghittoni et al., 2015). Early 
intervention and removal of premalignant cells are an effective means for preventing HPV-
associated cancers, HPV-associated tumors are challenging to treat. Conventional cancer therapies 
are often associated with toxicity and limited efficacy. This limited efficacy of traditional cancer 
therapy prompts the necessity to investigate novel approaches to the treatment of HPV-associated 
cancers (Williams et al., 2011).  
 
In addition to studies examining cancer chemotherapy and radiation, replication-competent viruses 
have been explored as an option for oncolytic viral therapy. Previously, sindbis virus and herpes 
simplex virus type 1 have been evaluated for their feasibility as oncolytic viral therapies for 
cervical cancers (Sokolowski et al., 2015; Unno et al., 2005). These studies successfully 
demonstrated the use of viruses as anticancer agents. Recently, the potential of Zika virus as the 
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oncolytic virus has been shown, wherein the permissiveness of neuroblastoma cells to Zika virus 
and its  association to CD24 expression was studied (Mazar et al., 2018). 
  
In my project, I investigated the Zika virus-mediated lysis of cervical cancer cells. I used three 
different cervical cancer cell lines to test their susceptibility to Zika virus infection and an 
established neuroblastoma cell line (IMR-32) as a positive control. Among the cervical cancer 
cells that were chosen, two of them, SiHa and CaSki possessed genome integrated with HPV-16 
while the third, HeLa, possessed HPV-18. Zika virus-induced noticeable cytopathic effects in 
HeLa and CaSki cells at a low MOIs (MOI- 0.3 and 1) and most, if not all infected cells were dead 
72 hours after infection. In contrast to HeLa and CaSki cells, SiHa cells showed cytopathic effects 
only after 72 hours after infection when a high MOI (MOI-10) was used; complete cell death 
occurred after 7 days. Two different MOIs, MOI - 1 and 10 were tested on all cell lines for 
optimization purposes. After observing the behavior of all cell lines when infected with two 
different MOIs, I elected to use an MOI of 1 across all experiments as two out of three cell lines 
were highly susceptible to infection at the corresponding MOI.  
 
 To confirm the permissiveness of cervical cancer cells to Zika virus infection, I measured the 
expression of NS1 and envelope protein after infection. Viral envelope protein is responsible for 
virus entry into the host cell and is one of the primary targets for neutralizing antibodies. NS1 is 
one of the non-structural proteins formed by post-translational cleavage of the Zika virus precursor 
protein (Calvet et al., 2016; Sager, 2018). Not only does NS1 play a key role in viral replication 
and late infection inside a host cell, but NS1 secreted into the extracellular space is involved in 
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evasion of the immune system. NS1 also contributes to viral pathogenesis by interacting with 
components from both the innate and adaptive immune systems, as well as with other host factors 
(Lovagnini Frutos et al., 2018; Shao et al., 2017). Therefore, when the expression of envelope and 
NS1 was observed as early as 48 hours after infection, it verified the fact that cervical cancer cells 
are highly permissive to the infection.  
 
Upon establishing the permissiveness of cervical cancer cells to Zika virus infection, I quantified 
the production of virions in samples at corresponding time points. Dr. Parks' lab kindly assisted in 
performing the plaque assay. 10-fold dilutions of the supernatant obtained from the infected 
samples were prepared to allow the viruses to form plaques. When the plaques were visible to the 
naked eye, the number of plaque-forming units (PFU) per milliliter were counted. Plaques obtained 
at every time pointed were counted, and the log10 of these plaques was expressed on a graph. The 
graph suggests that the viral titers peak somewhere between 48-72 hours after infection for all the 
cell lines. This 48-72- hour peak of viral production corresponds with the onset of increased cell 
death. Once cells undergo Zika virus-induced lysis and start dying, the viral titers reduce.  
 
The mechanism of cell death was determined in two ways, first, I observed by light microscopy 
that infected cells exhibited morphological changes consistent with apoptosis, cells were rounded, 
and they showed membrane blebs, and they were released from the plate. Caspase 3/7 assays 
confirmed that the mechanism of cell death was indeed apoptosis. 
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Based on the demonstrated importance of CD24 expression for infection of Zika virus in 
neuroblastoma cells I hypothesized that CD24 expression would also play a role in Zika virus 
infection of cervical cancer cells. Cervical cancer expressed low levels of CD24.   
 
To verify if CD24 plays a role in Zika virus infection, siRNA-mediated knockdown was performed 
on cervical cancer cells. When cervical cancer cells were infected with Zika virus, NS1 expression 
drastically reduced in CaSki cells while envelope protein expression remained unaffected. This 
reduction in NS1 expression indicated that CD24 might play a role in viral replication in the host. 
In Siha cells silencing of CD24 expression did not cause a significant change in NS1 or envelope 
production, which could either mean that 48 hours after infection is too early for CD24 to play a 
role in NS1 production or that Zika virus uses another mechanism in SiHa cells for replication. 
Additionally, these results were confirmed when I performed caspase 3/7 assay where I saw 
reduced apoptosis levels in siRNA-mediated CD24 knockdown samples of CaSki. 
 
To further understand the effect of Zika virus-induced lysis in cervical cancer, we can analyze p53 
and p21 expression. Innate and cell mediated immunity are downregulated by several specific 
mechanisms employed by HPV before transformation of healthy tissue into cervical cancer, which 
facilitate immune evasion and persistent viral infection (Castellsagué, 2008; Ghittoni et al., 2015). 
Oncogenes E2, E6 and E7 interfere with the expression of toll like receptors and IFNs. Perhaps, 
as a consequence of their ability to activate the cell cycle and stimulate DNA replication, E6 and 
E7 oncogenes also promote neoplastic transformation of HPV-infected cells. E6 and E7 promote 
proliferation of infected cells, blocking DNA repair and apoptosis, thereby leading to genetic 
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mutations and carcinogenesis (Amador-Molina et al., 2013; Skinner et al., 2016; Tobouti et al., 
2017; Williams et al., 2011). Interaction of E6 with critical tumor suppressor p53 promotes 
ubiquitination and subsequent proteosomal degradation. p53 levels rise due to cytotoxic stress. E6 
also contributes to tumorigenesis by activating telomerase, disrupting epithelial-cell adhesion, 
polarity and differentiation, altering gene transcription and reducing immune recognition of 
infected cells (Graham, 2017; Skinner et al., 2016). Therefore, studying p53 and p21 expression 
after Zika virus infection in cervical cancer may help in better elucidating the effects Zika virus on 
E6 expression. 
 
Despite advances in medical therapy, treatment of cervical cancer remains challenging. The burden 
of cervical cancer and other HPV associated malignancies in lower and middle-income nations 
have persisted. Thus, there is a global need for effective treatments of cervical cancer and other 
HPV-associated malignancies. Recently, a possible role for the cell surface glycoprotein CD24 in 
host cell specificity of Zika virus was reported. As an extension of this work, Zika viruses have 
been proposed as oncolytic therapy for treatment of neuroblastoma and other CD24 positive 
tumors. In this study, I determined the permissiveness of cervical cancer cells to Zika virus 
infection. Cytopathic effect induced by Zika virus in cervical cancer cell lines (HeLa, SiHa and 
CaSki) was assessed by light microscopy and by cytotoxicity assay. Cervical cancer cells showed 
susceptibility to Zika virus-induced apoptosis. Upon infection, the morphology of cervical cancer 
cells changed, exhibiting Zika virus-induced CPE. Cervical cancer cells’ expression of viral non-
structural protein 1 (NS1) after infection demonstrated viral protein translation. Quantitative 
plaque assays demonstrated the production of competent virions. CD24 expression in cervical 
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cancer cells was low but measurable. siRNA-mediated knockdown of CD24 resulted in reduced 
NS1 expression and reduced levels of virus-induced apoptosis. Collectively my data suggests a 
possible role for CD24 in Zika virus-induced apoptosis in cervical cancer cells. Zika virus-induced 
apoptosis of cultured cervical cancer cells presents the possibility for the use of Zika virus as a 
potential oncolytic therapy for cervical cancer. 
 
The treatment of many persistent, recurrent or metastatic cancers, like cervical cancer, are not 
successful or have had slow progress. One such persistent cancer is ovarian cancer. It is a complex 
disease with symptoms that are vague and not always gynecologic (Vasily Giannakeas, 2016). 
Cervical cancer and ovarian cancer share certain similar symptoms such as vaginal bleeding and 
pelvic pain, but the rest of the symptoms differ. Routine screening may help in prevention of 
cervical cancer where as currently, there is no screening method for ovarian cancer. Sindbis virus 
therapy has been proven effective in vitro and in vivo for certain cervical and ovarian cancers 
(Unno et al., 2005). Currently, the main method of treatment for ovarian cancers is surgical 
resection often followed by combination chemotherapy and radiotherapy in patients with advanced 
cancers (Sagae et al., 2016). However, additional options are required for a superior result of 
cancer therapy. The possibility for the use of Zika virus as a potential oncolytic therapy can help 
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